ProAssurance Corporation Share Price

Equities

PRA

US74267C1062

Property & Casualty Insurance

Market Closed - Nyse 21:00:02 08/05/2024 BST 5-day change 1st Jan Change
14.72 USD -2.90% Intraday chart for ProAssurance Corporation +10.01% +6.74%
Sales 2024 * 1.11B 88.66B Sales 2025 * 1.11B 88.9B Capitalization 751M 60.12B
Net income 2024 * - Net income 2025 * 30 2.4K EV / Sales 2024 * 0.68 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.68 x
P/E ratio 2024 *
63.1 x
P/E ratio 2025 *
25.1 x
Employees 1,094
Yield 2024 *
1.09%
Yield 2025 *
1.09%
Free-Float 79.24%
More Fundamentals * Assessed data
Dynamic Chart
Truist Securities Adjusts Price Target on ProAssurance to $16 From $14, Maintains Hold Rating MT
Transcript : ProAssurance Corporation, Q1 2024 Earnings Call, May 07, 2024
Earnings Flash (PRA) PROASSURANCE CORPORATION Posts Q1 EPS $0.08, vs. Street Est of $0.05 MT
Earnings Flash (PRA) PROASSURANCE CORPORATION Reports Q1 Revenue $284.7M, vs. Street Est of $271.9M MT
ProAssurance Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Piper Sandler Trims Price Target on ProAssurance to $15 From $16, Maintains Overweight Rating MT
Truist Securities Trims Price Target on ProAssurance to $14 From $15, Maintains Hold Rating MT
Transcript : ProAssurance Corporation, Q4 2023 Earnings Call, Feb 28, 2024
Earnings Flash (PRA) PROASSURANCE CORPORATION Posts Q4 Revenue $297M, vs. Street Est of $279.7M MT
Tranche Update on ProAssurance Corporation's Equity Buyback Plan announced on February 24, 2011. CI
ProAssurance Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Piper Sandler Trims Price Target on ProAssurance to $16 From $19, Maintains Overweight Rating MT
Truist Adjusts Price Target on ProAssurance to $15 From $20, Maintains Hold Rating MT
Transcript : ProAssurance Corporation, Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (PRA) PROASSURANCE CORPORATION Posts Q3 Revenue $275.7M, vs. Street Est of $279.4M MT
More news
1 day-2.90%
1 week+10.01%
Current month+10.18%
1 month+13.32%
3 months+14.02%
6 months-16.69%
Current year+6.74%
More quotes
1 week
13.64
Extreme 13.64
15.90
1 month
12.74
Extreme 12.74
15.90
Current year
11.76
Extreme 11.755
15.90
1 year
11.76
Extreme 11.755
19.38
3 years
11.76
Extreme 11.755
27.55
5 years
11.76
Extreme 11.755
42.03
10 years
11.76
Extreme 11.755
63.53
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 31/10/04
Director of Finance/CFO 56 31/08/18
Chief Investment Officer - 23/01/14
Members of the board TitleAgeSince
Chief Executive Officer 57 31/10/04
Chairman 71 30/04/16
Director/Board Member 73 20/01/14
More insiders
Date Price Change Volume
08/05/24 14.72 -2.90% 294,702
07/05/24 15.16 +9.70% 495,236
06/05/24 13.82 -0.07% 197,033
03/05/24 13.83 -0.65% 190,627
02/05/24 13.92 +4.04% 230,677

Delayed Quote Nyse, May 08, 2024 at 09:00 pm

More quotes
ProAssurance Corporation is a specialty insurer with expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers' compensation insurance. The Company's segments include Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance and Corporate. The Specialty Property and Casualty (Specialty P&C) segment is focused on professional liability insurance and medical technology liability insurance. Professional liability insurance is offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. The Workers' Compensation Insurance segment offers workers' compensation products in approximately 19 states in the East, South and Midwest regions of the continental United States. The Segregated Portfolio Cell Reinsurance segment includes the results of SPCs at Inova Re and Eastern Re, the Company's Cayman Islands SPC operations.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
14.72 USD
Average target price
16.75 USD
Spread / Average Target
+13.79%
Consensus